MedPath
FDA Approval

Calcium Acetate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 9, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Calcium acetate(667 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Suven Pharmaceuticals Limited

861468675

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Suven Pharmaceuitcals Ltd

Suven Pharmaceuticals Limited

Suven Pharmaceuticals Limited

677604288

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Calcium Acetate

Product Details

NDC Product Code
68022-0119
Application Number
ANDA211038
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 9, 2024
Code: Y882YXF34XClass: ACTIBQuantity: 667 mg in 1 1
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACTQuantity: 10 mg in 1 1
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UIClass: IACTQuantity: 6 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath